N6-(2-Carboxyethyl) Ibrutinib - Request Quote
N6-(2-Carboxyethyl) Ibrutinib
| SZ CAT No: | SZ-I005005 |
| CAS No | NA |
| Mol.F. | C28H28N6O4 |
| Mol.Wt. | 512.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
N6-(2-Carboxyethyl) Ibrutinib is chemically (R)-1-(3-(4-(2-Carboxyethyl)amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one;. N6-(2-Carboxyethyl) Ibrutinib is supplied with detailed characterization data compliant with regulatory guideline. N6-(2-Carboxyethyl) Ibrutinib can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ibrutinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality N6-(2-Carboxyethyl) Ibrutinib
Purchase N6-(2-Carboxyethyl) Ibrutinib
N6-(2-Carboxyethyl) Ibrutinib suppliers
N6-(2-Carboxyethyl) Ibrutinib manufacturers
N6-(2-Carboxyethyl) Ibrutinib price
Order N6-(2-Carboxyethyl) Ibrutinib
Enquire N6-(2-Carboxyethyl) Ibrutinib
N6-(2-Carboxyethyl) Ibrutinib cost
N6-(2-Carboxyethyl) Ibrutinib Supplier
N6-(2-Carboxyethyl) Ibrutinib Distributor
N6-(2-Carboxyethyl) Ibrutinib for Method Validation
Ibrutinib Reference Standard
N6-(2-Carboxyethyl) Ibrutinib for ANDA Filing
N6-(2-Carboxyethyl) Ibrutinib for Forced Degradation Studies
N6-(2-Carboxyethyl) Ibrutinib Identification Standards
N6-(2-Carboxyethyl) Ibrutinib for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


